Amesite Inc.

For the period ended Sep 30, 2025. Filed Oct 24, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 24, 2025

AMST$0.48-9.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Cash Flows (unaudited)

	For the Three Months Ended
	September 30,
2025 · 2024
Cash Flows from Operating Activities
Net Loss		$(642,266)	$(908,045)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		60,440	118,275
Stock-based compensation expense		72,252	65,440
Changes in operating assets and liabilities which used cash:
Accounts receivable		(4,003)	30,060
Prepaid expenses and other current assets		28,771	161,468
Accounts payable		(6,051)	7,109
Accrued compensation		133,858	32,800
Deferred revenue		(12,090)	24,375
Other accrued liabilities		(46,676)	(19,745)
Net cash and cash equivalents used in operating activities		(415,765)	(488,263)
Cash Flows from Investing Activities
Investment in capitalized software		(87,600)	(148,000)
Net cash and cash equivalents used in investing activities		(87,600)	(148,000)
Net decrease in cash, cash equivalents, and restricted cash		(503,365)	(636,263)
Cash, cash equivalents, and restricted cash - Beginning of period		2,433,418	2,071,016
Cash, cash equivalents, and restricted cash - End of period		$1,930,053	$1,434,753
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:
Issuance of common stock for public offering consulting expenses	$	-	$655,000

-6-

Amesite, Inc.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.